Your browser doesn't support javascript.
loading
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells.
Phetsouphanh, Chansavath; Khoo, Weng Hua; Jackson, Katherine; Klemm, Vera; Howe, Annett; Aggarwal, Anupriya; Akerman, Anouschka; Milogiannakis, Vanessa; Stella, Alberto Ospina; Rouet, Romain; Schofield, Peter; Faulks, Megan L; Law, Hannah; Danwilai, Thidarat; Starr, Mitchell; Munier, C Mee Ling; Christ, Daniel; Singh, Mandeep; Croucher, Peter I; Brilot-Turville, Fabienne; Turville, Stuart; Phan, Tri Giang; Dore, Gregory J; Darley, David; Cunningham, Philip; Matthews, Gail V; Kelleher, Anthony D; Zaunders, John J.
Afiliação
  • Phetsouphanh C; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Khoo WH; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Jackson K; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Klemm V; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Howe A; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Aggarwal A; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Akerman A; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Milogiannakis V; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Stella AO; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Rouet R; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Schofield P; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Faulks ML; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Law H; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Danwilai T; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Starr M; NSW State Reference Laboratory for HIV, St. Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.
  • Munier CML; NSW State Reference Laboratory for HIV, St. Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.
  • Christ D; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Singh M; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Croucher PI; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Brilot-Turville F; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Turville S; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Phan TG; Brain and Mind Centre, Children's Hospital at Westmead, University of Sydney, Sydney, NSW, Australia.
  • Dore GJ; Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW, Australia.
  • Darley D; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Cunningham P; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Matthews GV; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
  • Kelleher AD; Kirby Institute, University of New South Wales (UNSW), Sydney, NSW, Australia.
  • Zaunders JJ; Department of Infectious Diseases, St. Vincent's Hospital, Sydney, NSW, Australia.
Front Immunol ; 13: 1032911, 2022.
Article em En | MEDLINE | ID: mdl-36544780
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália